Comment
doi: 10.1093/bjd/ljac148.
Editor's Choice - John Ingram - February 2023
- PMID: 36763890
- DOI: 10.1093/bjd/ljac148
Item in Clipboard
Comment
Editor's Choice - John Ingram - February 2023
Br J Dermatol.
.
No abstract available
Comment on
-
Integrated safety analysis of baricitinib in adults with severe alopecia areata from two randomized clinical trials.Br J Dermatol. 2023 Feb 10;188(2):218-227. doi: 10.1093/bjd/ljac059. Br J Dermatol. 2023. PMID: 36763878
Similar articles
-
Editor's Choice - John Ingram - January 2023.Br J Dermatol. 2023 Jan 23;188(1):i-ii. doi: 10.1093/bjd/ljac147. Br J Dermatol. 2023. PMID: 36689532 No abstract available.
-
Editor's Choice - John Ingram - May 2023.Br J Dermatol. 2023 Apr 20;188(5):i-ii. doi: 10.1093/bjd/ljad090. Br J Dermatol. 2023. PMID: 37078762 No abstract available.
-
Editor's Choice - John Ingram June 2023.Br J Dermatol. 2023 May 24;188(6):i-ii. doi: 10.1093/bjd/ljad143. Br J Dermatol. 2023. PMID: 37226396 No abstract available.
-
Editor's Choice - John Ingram - August 2023.Br J Dermatol. 2023 Jul 17;189(2):i-iii. doi: 10.1093/bjd/ljad204. Br J Dermatol. 2023. PMID: 37459128 No abstract available.
-
Editor's Choice - John Ingram - Sep 2023.Br J Dermatol. 2023 Aug 24;189(3):i-ii. doi: 10.1093/bjd/ljad258. Br J Dermatol. 2023. PMID: 37620021 No abstract available.
Publication types
LinkOut - more resources
Full Text Sources
